查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
无创产前检测市场：按检测类型、应用、最终用户、地区划分——规模、份额、展望、机会分析，2022-2030 年
市场调查报告书
商品编码
1149894

无创产前检测市场：按检测类型、应用、最终用户、地区划分——规模、份额、展望、机会分析，2022-2030 年

Non-invasive Prenatal Testing Market, by Test Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

无创产前检测 (NIPT) 也称为无创产前筛查 (NIPS)。 NIPT 是一种用于确定胎儿染色体异常和紊乱的方法，通常由染色体缺陷或额外拷贝（非整倍体）引起。 NIPT 寻找在孕妇血液中循环的小脱氧核糖核酸 (DNA) 片段。这些小片段被称为游离 DNA，因为它们是自由漂浮的。 NIPT 用于检测 18 三体、13 三体、唐氏综合症、X 和 Y 染色体的缺失或额外拷贝。 NIPT 已被证明在 COVID-19 大流行期间有助于避免感染风险。在怀孕期间从母体血液中分离胎儿 DNA 和胎儿细胞的可能性揭示了升级无创产前检测 (NIPT) 的令人兴奋的机会。

市场动态

从付款人那里获得检测报销有望为全球无创产前检测市场的参与者提供有利可图的增长机会。鑑于 NIPT 测试的高成本，供应商可能会专注于为供应商提供的 NIPT 测试获得保险。此外，对健康教育的关注、对 NIPT 的补贴和遗传咨询也有望帮助市场增长。例如，2020年9月，中国復旦大学和英国伦敦大学学院的研究人员发现，与中国郑州的参与者相比，深圳更多的女性听过NIPT（87.30% vs. 64.03%），愿意接受NIPT （91.80% 对 80.43%），更有可能接受 NIPT 但报告的满意度较低（83.12% 对 54.54%）。

这项研究的主要特点

  • 本报告对全球无创产前检测市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
  • 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布和批准、市场趋势、区域前景以及主要参与者采用的竞争战略的重要见解。
  • 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，对全球无创产前检测市场的主要参与者进行了概况分析。
  • 参与这项研究的主要公司包括 F. Hoffmann-La Roche Ltd、BGI Group、Berry Genomics Co., Ltd.、Illumina, Inc.、Eurofin Scientific、Natera, Inc.、Sequenom, Inc.、Axia妇女健康、Eluthia、BillionToOne, Inc.、Quest Diagnostics Incorporation.、Igenomix、Agilent Technologies, Inc.、Laboratory Corporation of America Holdings.、PerkinElmer, Inc.、Thermo Fisher Scientific、Yourgene Health PLC
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 《全球无创产前检测市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球无创产前检测市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 按测试类型划分的市场概况
    • 市场概况：按应用分类
    • 市场概况：按最终用户分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 近期趋势
  • 收购和合作场景
  • 技术进步
  • 监管情景

第 4 章全球无创产前检测 (NIPT) 市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 总体影响
  • 对供需的影响
  • COVID-19 对市场的影响

第 5 章全球无创产前检测 (NIPT) 市场，按检测类型，2017-2030

  • 面板 1 测试
  • 小组 2 测试
  • 第 3 组测试

第 6 章全球无创产前检测 (NIPT) 市场：按应用分类，2017-2030

  • 三体性
  • 微缺失综合征
  • 性染色体异常
  • 其他

第 7 章全球无创产前检测 (NIPT) 市场：按最终用户分类，2017-2030

  • 医院
  • 诊断实验室
  • 妇产中心

第 8 章全球无创产前检测 (NIPT) 市场：按地区划分，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第9章竞争格局

  • F. Hoffmann-La Roche Ltd
  • BGI Group
  • Berry Genomics Co., Ltd.
  • Illumina, Inc.
  • Eurofin Scientific
  • Natera, Inc.
  • Sequenom, Inc.
  • Axia Women's Health
  • Eluthia
  • BillionToOne, Inc.
  • Quest Diagnostics Incorporation
  • Agilent Technologies, Inc.
  • Igenomix
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific
  • Yourgene Health PLC

第 10 章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI579

Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal screening (NIPS). It is a procedure used to determine the chromosomal abnormalities or disorders of the fetus which generally occur due to missing or an extra copy (aneuploidy) of a chromosome. NIPT examines small deoxyribonucleic acid (DNA) fragments which are circulating in the blood of pregnant woman. These small fragments are freely floating and hence are called cell-free DNA. NIPT is carried out for the detection of trisomy 18, trisomy 13, Down syndrome, and missing or extra copies of X and Y chromosomes. NIPT is found to be useful during the COVID-19 pandemic situation to avoid the risk of infection. The potential to isolate fetal DNA and fetal cells from maternal blood during pregnancy has revealed exciting opportunities for upgraded noninvasive prenatal testing (NIPT).

Market Dynamics

Obtaining reimbursement for tests from payers is expected to offer lucrative growth opportunities for players in the global non-invasive prenatal testing market. Vendors may focus on obtaining insurance coverage for NIPT tests offered by them, considering the high costs of these tests. Moreover, attention towards health education, subsidies for NIPT, and genetic counseling is also expected to aid in growth of the market. For instance, in September 2020, researchers from Fudan University, China, and University College London, U.K., reported that, in China, compared with Zhengzhou participants, a higher proportion of Shenzhen women had heard of NIPT (87.30% vs. 64.03%), were willing to receive NIPT (91.80% vs. 80.43%) and had taken NIPT (83.12% vs. 54.54%), while their satisfaction level was lower.

Key features of the study:

  • This report provides an in-depth analysis of the global non-invasive prenatal testing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive prenatal testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include include F. Hoffmann-La Roche Ltd, BGI Group, Berry Genomics Co., Ltd., Illumina, Inc., Eurofin Scientific, Natera, Inc., Sequenom, Inc., Axia Women's Health , Eluthia, BillionToOne, Inc., Quest Diagnostics Incorporation., Igenomix, Agilent Technologies, Inc., Laboratory Corporation of America Holdings., PerkinElmer, Inc., Thermo Fisher Scientific, Yourgene Health PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive prenatal testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive prenatal testing market

Detailed Segmentation:

  • Global Non-Invasive Prenatal Testing Market, By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
  • Global Non-Invasive Prenatal Testing Market, By Application:
    • Trisomy
    • Microdeletion Syndrome
    • Sex Chromosome abnormalities
    • Other
  • Global Non-Invasive Prenatal Testing Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
  • Global Non-Invasive Prenatal Testing Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
      • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
    • F.Hoffmann-La Roche Ltd
      • Company Overview
      • Product Portfolio
      • Market Presence
      • Financial Overview
      • Key Developments
    • Strategies
    • BGI Group
    • Berry Genomics Co., Ltd.
    • Illumina, Inc.
    • Eurofin Scientific
    • Natera, Inc.
    • Sequenom, Inc.
    • Axia Women's Health
    • Eluthia,
    • BillionToOne, Inc.
    • Quest Diagnostics Incorporation.
    • Igenomix
    • Agilent Technologies, Inc.
    • Laboratory Corporation of America Holdings.
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific
    • Yourgene Health PLC

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Test Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Advancements
  • Regulatory Scenario

4. Global Non-invasive Prenatal Testing (NIPT) Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Non-invasive Prenatal Testing (NIPT) Market, By Test Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Panel 1 Test
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Panel 2 Test
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Panel 3 Test
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Non-invasive Prenatal Testing (NIPT) Market, By Application, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Trisomy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Microdeletion Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Sex Chromosome Abnormalities
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Other
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Non-invasive Prenatal Testing (NIPT) Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Diagnostics Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Maternity Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Non-invasive Prenatal Testing (NIPT) Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BGI Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Berry Genomics Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eurofin Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Natera, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sequenom, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Axia Women's Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eluthia
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BillionToOne, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quest Diagnostics Incorporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Igenomix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Laboratory Corporation of America Holdings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PerkinElmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Yourgene Health PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us